| 0 |
CHOROIDAL DYSTROPHY |
29 |
0.6042 |
| 1 |
MENINGOMYELITIS HERPES |
15 |
0.4688 |
| 2 |
PROTOTHECOSIS |
37 |
0.3936 |
| 3 |
CHORIORETINAL ATROPHY |
67 |
0.3237 |
| 4 |
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA |
27 |
0.2647 |
| 5 |
MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND |
15 |
0.2542 |
| 6 |
ENGRAFTMENT SYNDROME |
142 |
0.2403 |
| 7 |
PRE-ENGRAFTMENT IMMUNE REACTION |
19 |
0.2375 |
| 8 |
CHOROIDAL INFARCTION |
28 |
0.2333 |
| 9 |
RETINOBLASTOMA |
25 |
0.2294 |
| 10 |
IRIS ATROPHY |
42 |
0.2029 |
| 11 |
ENGRAFT FAILURE |
58 |
0.2021 |
| 12 |
CLONAL HAEMATOPOIESIS |
15 |
0.1948 |
| 13 |
MALIGNANT TRANSFORMATION |
85 |
0.1893 |
| 14 |
NEUROBLASTOMA RECURRENT |
36 |
0.1773 |
| 15 |
BLOOD STEM CELL TRANSPLANT FAILURE |
37 |
0.1721 |
| 16 |
IDIOPATHIC PNEUMONIA SYNDROME |
51 |
0.1711 |
| 17 |
MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS |
20 |
0.1639 |
| 18 |
POEMS SYNDROME |
17 |
0.1619 |
| 19 |
ADENOVIRUS REACTIVATION |
22 |
0.1528 |
| 20 |
PNEUMONIA ADENOVIRAL |
30 |
0.1515 |
| 21 |
ADENOVIRAL HEPATITIS |
35 |
0.1489 |
| 22 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
28 |
0.1474 |
| 23 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
206 |
0.1458 |
| 24 |
GASTROENTERITIS ADENOVIRUS |
22 |
0.1401 |
| 25 |
LIGHT CHAIN DISEASE |
19 |
0.1310 |
| 26 |
RETINAL DEPIGMENTATION |
40 |
0.1307 |
| 27 |
ACUTE GRAFT VERSUS HOST DISEASE |
580 |
0.1266 |
| 28 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
350 |
0.1265 |
| 29 |
ADENOVIRUS INFECTION |
354 |
0.1219 |
| 30 |
IRIS NEOVASCULARISATION |
15 |
0.1200 |
| 31 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
33 |
0.1162 |
| 32 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
15 |
0.1154 |
| 33 |
VENOOCCLUSIVE LIVER DISEASE |
554 |
0.1121 |
| 34 |
RETINAL PIGMENT EPITHELIOPATHY |
48 |
0.1111 |
| 35 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
23 |
0.1106 |
| 36 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
79 |
0.1099 |
| 37 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
37 |
0.1054 |
| 38 |
VENOOCCLUSIVE DISEASE |
263 |
0.1049 |
| 39 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
95 |
0.1026 |
| 40 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
135 |
0.1025 |
| 41 |
CHRONIC GRAFT VERSUS HOST DISEASE |
367 |
0.1015 |
| 42 |
CYSTITIS VIRAL |
38 |
0.0992 |
| 43 |
VIRAL HAEMORRHAGIC CYSTITIS |
70 |
0.0983 |
| 44 |
EYE EXCISION |
20 |
0.0976 |
| 45 |
GRAFT VERSUS HOST DISEASE IN SKIN |
209 |
0.0948 |
| 46 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
199 |
0.0934 |
| 47 |
CHORIORETINAL DISORDER |
18 |
0.0914 |
| 48 |
AUTOIMMUNE NEUTROPENIA |
26 |
0.0900 |
| 49 |
PLASMACYTOSIS |
17 |
0.0890 |
| 50 |
MANTLE CELL LYMPHOMA RECURRENT |
38 |
0.0874 |
| 51 |
EXTRAOCULAR MUSCLE DISORDER |
27 |
0.0836 |
| 52 |
REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS |
26 |
0.0831 |
| 53 |
PLASMA CELL MYELOMA REFRACTORY |
110 |
0.0822 |
| 54 |
HUMAN HERPESVIRUS 6 INFECTION |
150 |
0.0793 |
| 55 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
19 |
0.0776 |
| 56 |
EPSTEIN-BARR VIRAEMIA |
86 |
0.0775 |
| 57 |
B-CELL TYPE ACUTE LEUKAEMIA |
54 |
0.0736 |
| 58 |
VIRAEMIA |
99 |
0.0714 |
| 59 |
GRAFT VERSUS HOST DISEASE |
509 |
0.0707 |
| 60 |
CENTRAL HYPOTHYROIDISM |
23 |
0.0695 |
| 61 |
NASAL ABSCESS |
16 |
0.0693 |
| 62 |
BONE MARROW TRANSPLANT REJECTION |
15 |
0.0682 |
| 63 |
B-CELL LYMPHOMA RECURRENT |
37 |
0.0681 |
| 64 |
OSTEOSARCOMA |
26 |
0.0675 |
| 65 |
BONE DEBRIDEMENT |
32 |
0.0663 |
| 66 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
287 |
0.0649 |
| 67 |
APOPTOSIS |
20 |
0.0647 |
| 68 |
B PRECURSOR TYPE ACUTE LEUKAEMIA |
25 |
0.0644 |
| 69 |
UREAPLASMA INFECTION |
26 |
0.0637 |
| 70 |
POLYCHROMASIA |
19 |
0.0633 |
| 71 |
PLASMA CELL MYELOMA RECURRENT |
204 |
0.0627 |
| 72 |
CEREBRAL TOXOPLASMOSIS |
58 |
0.0621 |
| 73 |
GRAFT VERSUS HOST DISEASE IN LIVER |
44 |
0.0615 |
| 74 |
STEM CELL TRANSPLANT |
151 |
0.0604 |
| 75 |
PLASMA CELL LEUKAEMIA |
36 |
0.0600 |
| 76 |
JC VIRUS INFECTION |
94 |
0.0587 |
| 77 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
21 |
0.0582 |
| 78 |
MORGANELLA INFECTION |
17 |
0.0580 |
| 79 |
WOUND DEBRIDEMENT |
24 |
0.0574 |
| 80 |
PRIMARY SEQUESTRUM |
51 |
0.0563 |
| 81 |
GASTROINTESTINAL FUNGAL INFECTION |
28 |
0.0544 |
| 82 |
BK VIRUS INFECTION |
178 |
0.0527 |
| 83 |
MONOCLONAL IMMUNOGLOBULIN INCREASED |
15 |
0.0524 |
| 84 |
MYELODYSPLASTIC SYNDROME |
722 |
0.0499 |
| 85 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
18 |
0.0495 |
| 86 |
MUCOSAL INFLAMMATION |
1281 |
0.0489 |
| 87 |
THROMBOTIC MICROANGIOPATHY |
472 |
0.0484 |
| 88 |
PLASMACYTOMA |
88 |
0.0472 |
| 89 |
IRIS ADHESIONS |
24 |
0.0468 |
| 90 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
237 |
0.0465 |
| 91 |
TRANSPLANT FAILURE |
114 |
0.0465 |
| 92 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
39 |
0.0463 |
| 93 |
OSTEOLYSIS |
94 |
0.0459 |
| 94 |
GASTROINTESTINAL MUCOSAL DISORDER |
30 |
0.0458 |
| 95 |
NEUTROPENIC COLITIS |
94 |
0.0454 |
| 96 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
128 |
0.0452 |
| 97 |
ENTEROCOCCAL BACTERAEMIA |
47 |
0.0443 |
| 98 |
PARAINFLUENZAE VIRUS INFECTION |
67 |
0.0440 |
| 99 |
ENTEROCOCCAL SEPSIS |
35 |
0.0432 |
| 100 |
TRANSPLANTATION COMPLICATION |
18 |
0.0429 |
| 101 |
KLEBSIELLA BACTERAEMIA |
40 |
0.0421 |
| 102 |
VITREOUS HAEMORRHAGE |
116 |
0.0419 |
| 103 |
CYSTITIS HAEMORRHAGIC |
166 |
0.0411 |
| 104 |
HUMAN HERPESVIRUS 8 INFECTION |
25 |
0.0411 |
| 105 |
PNEUMONIA CYTOMEGALOVIRAL |
79 |
0.0406 |
| 106 |
CYTOMEGALOVIRUS TEST POSITIVE |
71 |
0.0398 |
| 107 |
GRAFT VERSUS HOST DISEASE IN LUNG |
19 |
0.0397 |
| 108 |
HUMAN POLYOMAVIRUS INFECTION |
21 |
0.0395 |
| 109 |
METAPNEUMOVIRUS INFECTION |
31 |
0.0395 |
| 110 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
87 |
0.0394 |
| 111 |
SEQUESTRECTOMY |
26 |
0.0390 |
| 112 |
EPSTEIN-BARR VIRUS INFECTION |
241 |
0.0385 |
| 113 |
METASTATIC LYMPHOMA |
15 |
0.0384 |
| 114 |
ASEPTIC NECROSIS BONE |
30 |
0.0384 |
| 115 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
67 |
0.0379 |
| 116 |
FUSARIUM INFECTION |
26 |
0.0371 |
| 117 |
PULMONARY VENO-OCCLUSIVE DISEASE |
26 |
0.0371 |
| 118 |
SYSTEMIC MYCOSIS |
43 |
0.0368 |
| 119 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
24 |
0.0366 |
| 120 |
METASTASES TO BONE MARROW |
18 |
0.0360 |
| 121 |
CYTOMEGALOVIRUS VIRAEMIA |
160 |
0.0359 |
| 122 |
MONOCLONAL GAMMOPATHY |
22 |
0.0351 |
| 123 |
KLEBSIELLA SEPSIS |
39 |
0.0346 |
| 124 |
ACTINOMYCOSIS |
33 |
0.0344 |
| 125 |
LENTICULAR OPACITIES |
15 |
0.0343 |
| 126 |
ENCEPHALITIS CYTOMEGALOVIRUS |
15 |
0.0342 |
| 127 |
ACUTE MYELOID LEUKAEMIA |
534 |
0.0342 |
| 128 |
INFECTION REACTIVATION |
39 |
0.0341 |
| 129 |
SCEDOSPORIUM INFECTION |
24 |
0.0340 |
| 130 |
VARICELLA ZOSTER VIRUS INFECTION |
70 |
0.0337 |
| 131 |
APLASIA |
66 |
0.0337 |
| 132 |
SINUS POLYP |
19 |
0.0329 |
| 133 |
PLASMA CELL MYELOMA |
1286 |
0.0329 |
| 134 |
BACTERIAL SEPSIS |
106 |
0.0325 |
| 135 |
IIIRD NERVE PARALYSIS |
26 |
0.0321 |
| 136 |
ENCEPHALITIS VIRAL |
39 |
0.0320 |
| 137 |
SECOND PRIMARY MALIGNANCY |
266 |
0.0319 |
| 138 |
PREMATURE MENOPAUSE |
29 |
0.0314 |
| 139 |
ROTAVIRUS INFECTION |
18 |
0.0312 |
| 140 |
MINIMAL RESIDUAL DISEASE |
15 |
0.0311 |
| 141 |
PNEUMOCOCCAL SEPSIS |
20 |
0.0304 |
| 142 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
20 |
0.0303 |
| 143 |
CANDIDA SEPSIS |
27 |
0.0301 |
| 144 |
TOXOPLASMOSIS |
32 |
0.0296 |
| 145 |
AMYLOIDOSIS |
51 |
0.0295 |
| 146 |
RETINAL ISCHAEMIA |
18 |
0.0295 |
| 147 |
CYTOMEGALOVIRUS INFECTION |
480 |
0.0289 |
| 148 |
HERPES ZOSTER DISSEMINATED |
23 |
0.0286 |
| 149 |
CRYPTOSPORIDIOSIS INFECTION |
15 |
0.0286 |
| 150 |
FUNGAEMIA |
45 |
0.0286 |
| 151 |
PULMONARY MYCOSIS |
22 |
0.0282 |
| 152 |
RETINAL TOXICITY |
29 |
0.0282 |
| 153 |
OCULAR VASCULAR DISORDER |
23 |
0.0279 |
| 154 |
SYSTEMIC CANDIDA |
70 |
0.0279 |
| 155 |
AORTIC CALCIFICATION |
16 |
0.0275 |
| 156 |
ABDOMINAL COMPARTMENT SYNDROME |
17 |
0.0267 |
| 157 |
OBLITERATIVE BRONCHIOLITIS |
35 |
0.0267 |
| 158 |
CYTOMEGALOVIRUS CHORIORETINITIS |
52 |
0.0266 |
| 159 |
HEPATITIS E |
42 |
0.0266 |
| 160 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
20 |
0.0263 |
| 161 |
MULTIPLE MYELOMA |
119 |
0.0255 |
| 162 |
ESCHERICHIA BACTERAEMIA |
59 |
0.0251 |
| 163 |
STENOTROPHOMONAS INFECTION |
34 |
0.0251 |
| 164 |
FOLLICULAR LYMPHOMA |
22 |
0.0250 |
| 165 |
HYPOGAMMAGLOBULINAEMIA |
164 |
0.0249 |
| 166 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
53 |
0.0247 |
| 167 |
STAPHYLOCOCCAL BACTERAEMIA |
107 |
0.0246 |
| 168 |
OSTEOSCLEROSIS |
38 |
0.0241 |
| 169 |
BONE LESION |
87 |
0.0241 |
| 170 |
STREPTOCOCCAL BACTERAEMIA |
26 |
0.0239 |
| 171 |
RETINAL DEGENERATION |
31 |
0.0238 |
| 172 |
BONE SWELLING |
23 |
0.0238 |
| 173 |
MANTLE CELL LYMPHOMA |
36 |
0.0236 |
| 174 |
ENTEROCOCCAL INFECTION |
114 |
0.0236 |
| 175 |
ENTEROVIRUS INFECTION |
20 |
0.0231 |
| 176 |
VERTEBRAL FORAMINAL STENOSIS |
19 |
0.0231 |
| 177 |
PNEUMONIA FUNGAL |
91 |
0.0230 |
| 178 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
188 |
0.0228 |
| 179 |
STAPHYLOCOCCAL SEPSIS |
110 |
0.0223 |
| 180 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
17 |
0.0221 |
| 181 |
BRONCHOPULMONARY ASPERGILLOSIS |
171 |
0.0220 |
| 182 |
HAEMATOTOXICITY |
209 |
0.0220 |
| 183 |
HEPATITIS B REACTIVATION |
69 |
0.0217 |
| 184 |
BACTERAEMIA |
258 |
0.0217 |
| 185 |
POLYNEUROPATHY |
258 |
0.0215 |
| 186 |
CYTOPENIA |
263 |
0.0215 |
| 187 |
GASTROINTESTINAL TOXICITY |
103 |
0.0214 |
| 188 |
MICROANGIOPATHY |
20 |
0.0213 |
| 189 |
CYTOGENETIC ABNORMALITY |
24 |
0.0213 |
| 190 |
PARVOVIRUS B19 INFECTION |
19 |
0.0212 |
| 191 |
BONE MARROW TOXICITY |
25 |
0.0211 |
| 192 |
INTERVERTEBRAL DISC SPACE NARROWING |
17 |
0.0211 |
| 193 |
MUCOSAL EROSION |
19 |
0.0209 |
| 194 |
FEBRILE NEUTROPENIA |
1356 |
0.0204 |
| 195 |
ENDOCARDITIS BACTERIAL |
16 |
0.0203 |
| 196 |
VITH NERVE PARALYSIS |
23 |
0.0202 |
| 197 |
SINUSITIS FUNGAL |
16 |
0.0200 |
| 198 |
ASPERGILLUS INFECTION |
130 |
0.0198 |
| 199 |
ESCHERICHIA SEPSIS |
57 |
0.0196 |
| 200 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
144 |
0.0192 |
| 201 |
DIARRHOEA INFECTIOUS |
15 |
0.0190 |
| 202 |
MUCOUS MEMBRANE DISORDER |
26 |
0.0190 |
| 203 |
EJECTION FRACTION ABNORMAL |
23 |
0.0188 |
| 204 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
179 |
0.0187 |
| 205 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
23 |
0.0183 |
| 206 |
ABSCESS JAW |
19 |
0.0183 |
| 207 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
43 |
0.0182 |
| 208 |
CAPILLARY LEAK SYNDROME |
37 |
0.0179 |
| 209 |
VASCULAR CALCIFICATION |
19 |
0.0178 |
| 210 |
LEUKAEMIA RECURRENT |
30 |
0.0177 |
| 211 |
GASTROINTESTINAL INFLAMMATION |
139 |
0.0177 |
| 212 |
PNEUMONIA INFLUENZAL |
21 |
0.0176 |
| 213 |
ADENOCARCINOMA OF COLON |
33 |
0.0176 |
| 214 |
EXPOSED BONE IN JAW |
38 |
0.0175 |
| 215 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
45 |
0.0174 |
| 216 |
CYTOMEGALOVIRUS COLITIS |
40 |
0.0174 |
| 217 |
THERAPY PARTIAL RESPONDER |
270 |
0.0173 |
| 218 |
ADENOCARCINOMA GASTRIC |
16 |
0.0172 |
| 219 |
PSEUDOMONAL SEPSIS |
30 |
0.0171 |
| 220 |
FEBRILE BONE MARROW APLASIA |
72 |
0.0169 |
| 221 |
HISTIOCYTOSIS HAEMATOPHAGIC |
50 |
0.0168 |
| 222 |
HAEMATOLOGICAL INFECTION |
40 |
0.0163 |
| 223 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
15 |
0.0162 |
| 224 |
ACUTE LEUKAEMIA |
26 |
0.0161 |
| 225 |
POLYOMAVIRUS VIRAEMIA |
17 |
0.0160 |
| 226 |
AUTONOMIC NEUROPATHY |
16 |
0.0158 |
| 227 |
RENAL TUBULAR INJURY |
19 |
0.0156 |
| 228 |
PNEUMONIA STREPTOCOCCAL |
17 |
0.0155 |
| 229 |
GASTROINTESTINAL WALL THICKENING |
23 |
0.0154 |
| 230 |
DIFFUSE LARGE B-CELL LYMPHOMA |
116 |
0.0150 |
| 231 |
BLOOD IMMUNOGLOBULIN G INCREASED |
18 |
0.0148 |
| 232 |
TRANSITIONAL CELL CARCINOMA |
19 |
0.0146 |
| 233 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
15 |
0.0146 |
| 234 |
ASPERGILLOSIS |
19 |
0.0145 |
| 235 |
CARDIAC AMYLOIDOSIS |
16 |
0.0145 |
| 236 |
MYCOBACTERIAL INFECTION |
25 |
0.0145 |
| 237 |
FEBRILE INFECTION |
17 |
0.0144 |
| 238 |
NEUTROPENIC SEPSIS |
103 |
0.0144 |
| 239 |
DEVICE RELATED SEPSIS |
29 |
0.0144 |
| 240 |
HYPOPERFUSION |
15 |
0.0143 |
| 241 |
PERIPHERAL SENSORY NEUROPATHY |
83 |
0.0142 |
| 242 |
CLOSTRIDIUM COLITIS |
17 |
0.0140 |
| 243 |
PHARYNGEAL INFLAMMATION |
17 |
0.0140 |
| 244 |
LYMPHOPROLIFERATIVE DISORDER |
41 |
0.0139 |
| 245 |
RHINOVIRUS INFECTION |
54 |
0.0139 |
| 246 |
PULMONARY TOXICITY |
98 |
0.0138 |
| 247 |
KLEBSIELLA INFECTION |
70 |
0.0138 |
| 248 |
NEUROLOGICAL DECOMPENSATION |
32 |
0.0138 |
| 249 |
HAEMOLYTIC URAEMIC SYNDROME |
32 |
0.0138 |
| 250 |
MULTI-ORGAN FAILURE |
237 |
0.0137 |
| 251 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
385 |
0.0136 |
| 252 |
GASTROENTERITIS NOROVIRUS |
18 |
0.0135 |
| 253 |
STREPTOCOCCAL SEPSIS |
16 |
0.0135 |
| 254 |
MENINGITIS BACTERIAL |
19 |
0.0133 |
| 255 |
PNEUMONIA PSEUDOMONAL |
20 |
0.0130 |
| 256 |
KYPHOSIS |
23 |
0.0130 |
| 257 |
PNEUMONIA PNEUMOCOCCAL |
19 |
0.0128 |
| 258 |
CUTANEOUS T-CELL LYMPHOMA |
16 |
0.0127 |
| 259 |
BLOOD CULTURE POSITIVE |
38 |
0.0127 |
| 260 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
22 |
0.0126 |
| 261 |
APLASTIC ANAEMIA |
66 |
0.0126 |
| 262 |
SOFT TISSUE INFECTION |
23 |
0.0126 |
| 263 |
LUNG INFILTRATION |
111 |
0.0126 |
| 264 |
PULMONARY HAEMORRHAGE |
98 |
0.0125 |
| 265 |
EMBOLISM ARTERIAL |
15 |
0.0125 |
| 266 |
OTOTOXICITY |
23 |
0.0124 |
| 267 |
PANCYTOPENIA |
690 |
0.0123 |
| 268 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
42 |
0.0122 |
| 269 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
216 |
0.0122 |
| 270 |
HEPATITIS B |
73 |
0.0121 |
| 271 |
NEOPLASM RECURRENCE |
41 |
0.0121 |
| 272 |
MASTICATION DISORDER |
37 |
0.0121 |
| 273 |
KERATOPATHY |
19 |
0.0120 |
| 274 |
ARTERIAL THROMBOSIS |
23 |
0.0119 |
| 275 |
RETINAL ARTERY OCCLUSION |
30 |
0.0119 |
| 276 |
BONE MARROW FAILURE |
241 |
0.0118 |
| 277 |
OPTIC ATROPHY |
19 |
0.0117 |
| 278 |
CLOSTRIDIUM DIFFICILE COLITIS |
123 |
0.0116 |
| 279 |
NEOPLASM SKIN |
18 |
0.0116 |
| 280 |
PNEUMATOSIS INTESTINALIS |
33 |
0.0116 |
| 281 |
H1N1 INFLUENZA |
16 |
0.0114 |
| 282 |
LYMPHOPENIA |
156 |
0.0110 |
| 283 |
PSEUDOMONAS INFECTION |
94 |
0.0110 |
| 284 |
LICHENOID KERATOSIS |
25 |
0.0109 |
| 285 |
SEPTIC SHOCK |
471 |
0.0108 |
| 286 |
CARDIOTOXICITY |
95 |
0.0106 |
| 287 |
GENE MUTATION |
21 |
0.0106 |
| 288 |
VENTRICULAR HYPOKINESIA |
34 |
0.0106 |
| 289 |
ENTEROCOLITIS |
61 |
0.0106 |
| 290 |
MYELOPATHY |
20 |
0.0105 |
| 291 |
KIDNEY FIBROSIS |
18 |
0.0104 |
| 292 |
SPONDYLOLISTHESIS |
18 |
0.0104 |
| 293 |
ENTERITIS |
66 |
0.0103 |
| 294 |
OSTEITIS |
26 |
0.0103 |
| 295 |
SQUAMOUS CELL CARCINOMA OF SKIN |
62 |
0.0103 |
| 296 |
THROMBOCYTOPENIA |
1148 |
0.0103 |
| 297 |
HEPATOSPLENOMEGALY |
26 |
0.0101 |
| 298 |
JUGULAR VEIN THROMBOSIS |
18 |
0.0101 |
| 299 |
AORTIC ARTERIOSCLEROSIS |
26 |
0.0101 |
| 300 |
NEPHROPATHY TOXIC |
113 |
0.0101 |
| 301 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
101 |
0.0100 |
| 302 |
EMBOLISM VENOUS |
30 |
0.0099 |
| 303 |
ACUTE SINUSITIS |
17 |
0.0098 |
| 304 |
ESCHERICHIA INFECTION |
81 |
0.0098 |
| 305 |
ENCEPHALITIS |
68 |
0.0098 |
| 306 |
NOCARDIOSIS |
25 |
0.0098 |
| 307 |
CLOSTRIDIAL INFECTION |
33 |
0.0097 |
| 308 |
LEUKOENCEPHALOPATHY |
36 |
0.0097 |
| 309 |
TUMOUR LYSIS SYNDROME |
84 |
0.0095 |
| 310 |
ATELECTASIS |
92 |
0.0095 |
| 311 |
PARESIS |
21 |
0.0094 |
| 312 |
HEPATIC CYST |
32 |
0.0094 |
| 313 |
RETINOPATHY |
35 |
0.0094 |
| 314 |
BACTERIAL INFECTION |
175 |
0.0094 |
| 315 |
LUNG CONSOLIDATION |
26 |
0.0093 |
| 316 |
MUCORMYCOSIS |
24 |
0.0092 |
| 317 |
BASAL CELL CARCINOMA |
144 |
0.0092 |
| 318 |
NEUTROPENIA |
1244 |
0.0091 |
| 319 |
PURULENT DISCHARGE |
39 |
0.0091 |
| 320 |
TOOTH EXTRACTION |
112 |
0.0090 |
| 321 |
HYPERAMMONAEMIA |
45 |
0.0090 |
| 322 |
BONE MARROW TRANSPLANT |
17 |
0.0090 |
| 323 |
PULMONARY ALVEOLAR HAEMORRHAGE |
50 |
0.0089 |
| 324 |
RENAL TUBULAR DISORDER |
25 |
0.0089 |
| 325 |
PATHOLOGICAL FRACTURE |
45 |
0.0089 |
| 326 |
COMPUTERISED TOMOGRAM ABNORMAL |
20 |
0.0088 |
| 327 |
BONE DISORDER |
159 |
0.0087 |
| 328 |
RETINITIS |
15 |
0.0087 |
| 329 |
VENOUS THROMBOSIS |
34 |
0.0087 |
| 330 |
LOBAR PNEUMONIA |
16 |
0.0086 |
| 331 |
LUNG ADENOCARCINOMA |
26 |
0.0086 |
| 332 |
HERPES SIMPLEX |
56 |
0.0086 |
| 333 |
PSEUDOMEMBRANOUS COLITIS |
19 |
0.0085 |
| 334 |
IMMUNE THROMBOCYTOPENIC PURPURA |
24 |
0.0085 |
| 335 |
INVASIVE DUCTAL BREAST CARCINOMA |
23 |
0.0085 |
| 336 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
73 |
0.0084 |
| 337 |
HYPOREFLEXIA |
16 |
0.0083 |
| 338 |
BRAIN ABSCESS |
21 |
0.0083 |
| 339 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
22 |
0.0083 |
| 340 |
HYPERBILIRUBINAEMIA |
85 |
0.0082 |
| 341 |
PNEUMONIA KLEBSIELLA |
15 |
0.0082 |
| 342 |
SEPSIS |
908 |
0.0081 |
| 343 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
31 |
0.0081 |
| 344 |
OPPORTUNISTIC INFECTION |
15 |
0.0081 |
| 345 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
18 |
0.0081 |
| 346 |
ILEUS PARALYTIC |
36 |
0.0081 |
| 347 |
RETINAL HAEMORRHAGE |
57 |
0.0080 |
| 348 |
SMALL INTESTINAL PERFORATION |
15 |
0.0080 |
| 349 |
CANDIDIASIS |
32 |
0.0080 |
| 350 |
BONE MARROW DISORDER |
24 |
0.0079 |
| 351 |
NEUROPATHY PERIPHERAL |
755 |
0.0079 |
| 352 |
OSTEONECROSIS |
260 |
0.0079 |
| 353 |
PNEUMONIA VIRAL |
25 |
0.0078 |
| 354 |
RENAL CELL CARCINOMA |
38 |
0.0078 |
| 355 |
ATROPHY |
15 |
0.0077 |
| 356 |
CYTOKINE RELEASE SYNDROME |
154 |
0.0077 |
| 357 |
ORAL FUNGAL INFECTION |
21 |
0.0077 |
| 358 |
ISCHAEMIA |
35 |
0.0076 |
| 359 |
DEAFNESS NEUROSENSORY |
25 |
0.0076 |
| 360 |
OESOPHAGITIS |
83 |
0.0076 |
| 361 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
22 |
0.0075 |
| 362 |
MYOSITIS |
67 |
0.0075 |
| 363 |
HEPATITIS FULMINANT |
22 |
0.0074 |
| 364 |
SPINAL OSTEOARTHRITIS |
65 |
0.0074 |
| 365 |
OSTEONECROSIS OF JAW |
182 |
0.0073 |
| 366 |
LEFT VENTRICULAR DYSFUNCTION |
49 |
0.0073 |
| 367 |
ORGANISING PNEUMONIA |
36 |
0.0073 |
| 368 |
HEPATOMEGALY |
71 |
0.0072 |
| 369 |
RADICULOPATHY |
19 |
0.0072 |
| 370 |
HYPERCALCAEMIA |
89 |
0.0072 |
| 371 |
DUODENITIS |
22 |
0.0072 |
| 372 |
CANDIDA INFECTION |
121 |
0.0072 |
| 373 |
MYELOSUPPRESSION |
258 |
0.0072 |
| 374 |
CARDIOMYOPATHY |
105 |
0.0071 |
| 375 |
HYPERVOLAEMIA |
35 |
0.0071 |
| 376 |
OSTEOMYELITIS |
128 |
0.0071 |
| 377 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
35 |
0.0070 |
| 378 |
NECROSIS |
39 |
0.0070 |
| 379 |
DISEASE PROGRESSION |
827 |
0.0070 |
| 380 |
EXOPHTHALMOS |
15 |
0.0070 |
| 381 |
CHRONIC MYELOID LEUKAEMIA |
32 |
0.0069 |
| 382 |
PERIODONTITIS |
15 |
0.0069 |
| 383 |
SKIN TOXICITY |
39 |
0.0069 |
| 384 |
PERICARDIAL EFFUSION |
159 |
0.0069 |
| 385 |
NEUROTOXICITY |
120 |
0.0068 |
| 386 |
ESCHERICHIA URINARY TRACT INFECTION |
29 |
0.0068 |
| 387 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
21 |
0.0068 |
| 388 |
MULTIPLE-DRUG RESISTANCE |
21 |
0.0068 |
| 389 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
107 |
0.0067 |
| 390 |
RETINAL DETACHMENT |
62 |
0.0067 |
| 391 |
GASTROINTESTINAL INJURY |
18 |
0.0067 |
| 392 |
HYPOALBUMINAEMIA |
52 |
0.0067 |
| 393 |
HAEMATOLOGICAL MALIGNANCY |
19 |
0.0067 |
| 394 |
HYPOPHOSPHATAEMIA |
49 |
0.0066 |
| 395 |
AORTIC VALVE INCOMPETENCE |
28 |
0.0066 |
| 396 |
VENTRICULAR DYSFUNCTION |
17 |
0.0065 |
| 397 |
ACTINIC KERATOSIS |
17 |
0.0065 |
| 398 |
CARDIAC TAMPONADE |
31 |
0.0065 |
| 399 |
GASTROINTESTINAL NECROSIS |
19 |
0.0065 |
| 400 |
GROWTH RETARDATION |
19 |
0.0064 |
| 401 |
APLASIA PURE RED CELL |
22 |
0.0064 |
| 402 |
RECURRENT CANCER |
26 |
0.0064 |
| 403 |
ORAL DISORDER |
46 |
0.0063 |
| 404 |
FAILURE TO THRIVE |
32 |
0.0062 |
| 405 |
RESPIRATORY FAILURE |
449 |
0.0062 |
| 406 |
HEPATOTOXICITY |
136 |
0.0061 |
| 407 |
HAEMODYNAMIC INSTABILITY |
46 |
0.0060 |
| 408 |
COVID-19 PNEUMONIA |
71 |
0.0060 |
| 409 |
LYMPHOMA |
92 |
0.0059 |
| 410 |
LEUKAEMIA |
56 |
0.0059 |
| 411 |
ENCEPHALOPATHY |
145 |
0.0059 |
| 412 |
HAEMORRHAGE URINARY TRACT |
15 |
0.0059 |
| 413 |
METASTASIS |
42 |
0.0059 |
| 414 |
PNEUMONITIS |
159 |
0.0058 |
| 415 |
LEUKOPENIA |
290 |
0.0058 |
| 416 |
VASCULAR DEVICE INFECTION |
26 |
0.0057 |
| 417 |
CARDIAC FAILURE ACUTE |
38 |
0.0057 |
| 418 |
BRONCHIOLITIS |
20 |
0.0057 |
| 419 |
ACUTE RESPIRATORY FAILURE |
109 |
0.0057 |
| 420 |
PNEUMONIA BACTERIAL |
52 |
0.0057 |
| 421 |
METABOLIC ENCEPHALOPATHY |
17 |
0.0057 |
| 422 |
OESOPHAGEAL STENOSIS |
16 |
0.0056 |
| 423 |
EYELID PTOSIS |
57 |
0.0056 |
| 424 |
COMPRESSION FRACTURE |
30 |
0.0056 |
| 425 |
HYPERURICAEMIA |
23 |
0.0056 |
| 426 |
PULMONARY HYPERTENSION |
116 |
0.0056 |
| 427 |
PAPILLOEDEMA |
25 |
0.0055 |
| 428 |
SUSPECTED OFF LABEL USE |
25 |
0.0055 |
| 429 |
CARDIOMEGALY |
68 |
0.0055 |
| 430 |
DRUG RESISTANCE |
142 |
0.0055 |
| 431 |
ATRIAL FLUTTER |
44 |
0.0055 |
| 432 |
COLITIS |
209 |
0.0055 |
| 433 |
DRUG TOXICITY |
75 |
0.0055 |
| 434 |
TRANSPLANT REJECTION |
44 |
0.0055 |
| 435 |
CLONUS |
15 |
0.0055 |
| 436 |
STOMATITIS |
332 |
0.0055 |
| 437 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
56 |
0.0054 |
| 438 |
EYELID OEDEMA |
63 |
0.0054 |
| 439 |
EMBOLISM |
45 |
0.0054 |
| 440 |
NEPHROTIC SYNDROME |
37 |
0.0054 |
| 441 |
HERPES VIRUS INFECTION |
31 |
0.0054 |
| 442 |
PATHOGEN RESISTANCE |
49 |
0.0054 |
| 443 |
MALIGNANT MELANOMA |
72 |
0.0054 |
| 444 |
INFECTION |
774 |
0.0053 |
| 445 |
LOOSE TOOTH |
17 |
0.0053 |
| 446 |
FIBROSIS |
16 |
0.0052 |
| 447 |
HYPOXIA |
183 |
0.0052 |
| 448 |
ILEUS |
63 |
0.0051 |
| 449 |
DISEASE RECURRENCE |
241 |
0.0051 |
| 450 |
HERPES ZOSTER |
290 |
0.0050 |
| 451 |
BRONCHOPNEUMONIA |
17 |
0.0050 |
| 452 |
RESPIRATORY TRACT INFECTION |
129 |
0.0049 |
| 453 |
RENAL FAILURE CHRONIC |
38 |
0.0049 |
| 454 |
PLEURAL EFFUSION |
298 |
0.0049 |
| 455 |
ARTHRITIS BACTERIAL |
20 |
0.0049 |
| 456 |
DEVICE RELATED INFECTION |
75 |
0.0049 |
| 457 |
MITRAL VALVE INCOMPETENCE |
55 |
0.0049 |
| 458 |
RESPIRATORY DISTRESS |
134 |
0.0049 |
| 459 |
OLIGURIA |
30 |
0.0048 |
| 460 |
ANGIOPATHY |
27 |
0.0048 |
| 461 |
SQUAMOUS CELL CARCINOMA |
45 |
0.0048 |
| 462 |
ASCITES |
139 |
0.0047 |
| 463 |
HAEMOLYTIC ANAEMIA |
42 |
0.0047 |
| 464 |
CEREBRAL ISCHAEMIA |
24 |
0.0047 |
| 465 |
HEPATIC LESION |
20 |
0.0046 |
| 466 |
IMMUNE-MEDIATED ENTEROCOLITIS |
17 |
0.0046 |
| 467 |
SPINAL CORD COMPRESSION |
18 |
0.0046 |
| 468 |
FLUID OVERLOAD |
67 |
0.0046 |
| 469 |
SPINAL COMPRESSION FRACTURE |
38 |
0.0046 |
| 470 |
PULSELESS ELECTRICAL ACTIVITY |
19 |
0.0045 |
| 471 |
DECUBITUS ULCER |
37 |
0.0045 |
| 472 |
TOXIC ENCEPHALOPATHY |
23 |
0.0045 |
| 473 |
TRICUSPID VALVE INCOMPETENCE |
36 |
0.0045 |
| 474 |
GINGIVAL SWELLING |
20 |
0.0045 |
| 475 |
TOOTH ABSCESS |
46 |
0.0045 |
| 476 |
STREPTOCOCCAL INFECTION |
25 |
0.0045 |
| 477 |
ENDOCARDITIS |
23 |
0.0045 |
| 478 |
HYPOVOLAEMIA |
26 |
0.0044 |
| 479 |
PERIORBITAL OEDEMA |
23 |
0.0044 |
| 480 |
PULMONARY ARTERIAL HYPERTENSION |
64 |
0.0044 |
| 481 |
HYPERNATRAEMIA |
22 |
0.0044 |
| 482 |
HAEMODIALYSIS |
37 |
0.0044 |
| 483 |
JAW DISORDER |
24 |
0.0044 |
| 484 |
TOXIC SKIN ERUPTION |
44 |
0.0044 |
| 485 |
FUNGAL INFECTION |
145 |
0.0043 |
| 486 |
GUILLAIN-BARRE SYNDROME |
21 |
0.0043 |
| 487 |
GRANULOMA |
15 |
0.0043 |
| 488 |
CEREBRAL ATROPHY |
17 |
0.0043 |
| 489 |
NO THERAPEUTIC RESPONSE |
52 |
0.0043 |
| 490 |
DEEP VEIN THROMBOSIS |
276 |
0.0042 |
| 491 |
NEUTROPHIL COUNT DECREASED |
172 |
0.0042 |
| 492 |
LEFT VENTRICULAR HYPERTROPHY |
18 |
0.0042 |
| 493 |
DISSEMINATED INTRAVASCULAR COAGULATION |
59 |
0.0042 |
| 494 |
BLOOD BILIRUBIN INCREASED |
113 |
0.0042 |
| 495 |
RENAL CYST |
33 |
0.0042 |
| 496 |
RENAL FAILURE ACUTE |
176 |
0.0041 |
| 497 |
ADRENAL INSUFFICIENCY |
50 |
0.0041 |
| 498 |
INTERVERTEBRAL DISC DEGENERATION |
38 |
0.0041 |
| 499 |
STAPHYLOCOCCAL INFECTION |
134 |
0.0041 |
| 500 |
LUNG INFECTION |
63 |
0.0041 |
| 501 |
HEPATIC FAILURE |
122 |
0.0040 |
| 502 |
SPINAL COLUMN STENOSIS |
19 |
0.0040 |
| 503 |
PARTIAL SEIZURES |
21 |
0.0040 |
| 504 |
PNEUMOTHORAX |
63 |
0.0040 |
| 505 |
IMMUNOSUPPRESSION |
35 |
0.0040 |
| 506 |
METABOLIC DISORDER |
23 |
0.0040 |
| 507 |
ANAEMIA |
751 |
0.0039 |
| 508 |
EJECTION FRACTION DECREASED |
61 |
0.0039 |
| 509 |
PRODUCT USE IN UNAPPROVED INDICATION |
967 |
0.0039 |
| 510 |
GINGIVITIS |
21 |
0.0039 |
| 511 |
DIVERTICULUM INTESTINAL |
17 |
0.0039 |
| 512 |
HYPERTRANSAMINASAEMIA |
27 |
0.0039 |
| 513 |
ACUTE KIDNEY INJURY |
592 |
0.0039 |
| 514 |
BRONCHIECTASIS |
26 |
0.0039 |
| 515 |
NEOPLASM PROGRESSION |
134 |
0.0038 |
| 516 |
TACHYPNOEA |
52 |
0.0038 |
| 517 |
EXERCISE TOLERANCE DECREASED |
22 |
0.0038 |
| 518 |
INTESTINAL ISCHAEMIA |
21 |
0.0038 |
| 519 |
DERMATITIS EXFOLIATIVE |
19 |
0.0038 |
| 520 |
PULMONARY OEDEMA |
170 |
0.0038 |
| 521 |
CARDIAC FAILURE |
301 |
0.0037 |
| 522 |
TOXICITY TO VARIOUS AGENTS |
632 |
0.0037 |
| 523 |
MENINGITIS |
25 |
0.0037 |
| 524 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
22 |
0.0037 |
| 525 |
ODYNOPHAGIA |
22 |
0.0037 |
| 526 |
RENAL FAILURE |
489 |
0.0037 |
| 527 |
CLOSTRIDIUM DIFFICILE INFECTION |
80 |
0.0037 |
| 528 |
DIVERTICULUM |
26 |
0.0037 |
| 529 |
SERUM FERRITIN INCREASED |
19 |
0.0036 |
| 530 |
PNEUMONIA |
1163 |
0.0036 |
| 531 |
INTESTINAL PERFORATION |
40 |
0.0036 |
| 532 |
ACUTE PULMONARY OEDEMA |
20 |
0.0036 |
| 533 |
AGRANULOCYTOSIS |
66 |
0.0035 |
| 534 |
INTENTIONAL PRODUCT USE ISSUE |
311 |
0.0035 |
| 535 |
STATUS EPILEPTICUS |
40 |
0.0035 |
| 536 |
BLOOD ALBUMIN DECREASED |
28 |
0.0035 |
| 537 |
INTERVERTEBRAL DISC DISORDER |
15 |
0.0035 |
| 538 |
LUNG NEOPLASM |
15 |
0.0035 |
| 539 |
CACHEXIA |
18 |
0.0035 |
| 540 |
GASTROENTERITIS |
51 |
0.0035 |
| 541 |
GENERALISED OEDEMA |
43 |
0.0035 |
| 542 |
MYOPATHY |
30 |
0.0035 |
| 543 |
PYREXIA |
1186 |
0.0034 |
| 544 |
TRANSAMINASES INCREASED |
76 |
0.0034 |
| 545 |
PHYSICAL DISABILITY |
15 |
0.0034 |
| 546 |
HAEMOLYSIS |
26 |
0.0034 |
| 547 |
COAGULOPATHY |
56 |
0.0034 |
| 548 |
PULMONARY CONGESTION |
44 |
0.0033 |
| 549 |
PAIN IN JAW |
94 |
0.0033 |
| 550 |
RENAL IMPAIRMENT |
278 |
0.0033 |
| 551 |
TUBULOINTERSTITIAL NEPHRITIS |
62 |
0.0033 |
| 552 |
LYMPHADENOPATHY |
117 |
0.0033 |
| 553 |
HYPOKALAEMIA |
152 |
0.0033 |
| 554 |
GASTROINTESTINAL INFECTION |
29 |
0.0032 |
| 555 |
OSTEOPENIA |
49 |
0.0032 |
| 556 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
177 |
0.0032 |
| 557 |
MALNUTRITION |
36 |
0.0032 |
| 558 |
ECCHYMOSIS |
22 |
0.0032 |
| 559 |
PROTHROMBIN TIME PROLONGED |
19 |
0.0032 |
| 560 |
EXOSTOSIS |
29 |
0.0032 |
| 561 |
ARTERIOSCLEROSIS CORONARY ARTERY |
21 |
0.0032 |
| 562 |
VIRAL INFECTION |
105 |
0.0032 |
| 563 |
BRONCHOSPASM |
45 |
0.0032 |
| 564 |
NEUROLOGICAL SYMPTOM |
18 |
0.0031 |
| 565 |
MENTAL STATUS CHANGES |
87 |
0.0031 |
| 566 |
RIB FRACTURE |
64 |
0.0031 |
| 567 |
ATRIAL FIBRILLATION |
302 |
0.0031 |
| 568 |
ACUTE HEPATIC FAILURE |
42 |
0.0031 |
| 569 |
HYPOCALCAEMIA |
58 |
0.0031 |
| 570 |
ELECTROLYTE IMBALANCE |
35 |
0.0030 |
| 571 |
BLOOD DISORDER |
24 |
0.0030 |
| 572 |
INTERSTITIAL LUNG DISEASE |
145 |
0.0030 |
| 573 |
DENTAL CARIES |
33 |
0.0030 |
| 574 |
PLATELET COUNT DECREASED |
313 |
0.0029 |
| 575 |
MASS |
41 |
0.0029 |
| 576 |
GLOMERULAR FILTRATION RATE DECREASED |
36 |
0.0029 |
| 577 |
ORTHOSTATIC HYPOTENSION |
51 |
0.0029 |
| 578 |
PARANOIA |
50 |
0.0029 |
| 579 |
OFF LABEL USE |
2533 |
0.0029 |
| 580 |
PYELONEPHRITIS |
25 |
0.0029 |
| 581 |
EMPHYSEMA |
29 |
0.0029 |
| 582 |
ATAXIA |
34 |
0.0029 |
| 583 |
IMPAIRED HEALING |
94 |
0.0029 |
| 584 |
CARDIOGENIC SHOCK |
41 |
0.0029 |
| 585 |
GRANULOCYTOPENIA |
16 |
0.0028 |
| 586 |
IMMUNE SYSTEM DISORDER |
37 |
0.0028 |
| 587 |
MALIGNANT NEOPLASM PROGRESSION |
287 |
0.0028 |
| 588 |
ANURIA |
24 |
0.0028 |
| 589 |
DEFORMITY |
26 |
0.0028 |
| 590 |
ACUTE CORONARY SYNDROME |
23 |
0.0028 |
| 591 |
LUNG DISORDER |
136 |
0.0028 |
| 592 |
PULMONARY FIBROSIS |
53 |
0.0028 |
| 593 |
JOINT EFFUSION |
19 |
0.0028 |
| 594 |
NERVOUS SYSTEM DISORDER |
86 |
0.0028 |
| 595 |
HAEMORRHAGE INTRACRANIAL |
41 |
0.0027 |
| 596 |
LARGE INTESTINE PERFORATION |
19 |
0.0027 |
| 597 |
DECREASED INTEREST |
16 |
0.0027 |
| 598 |
RIGHT VENTRICULAR FAILURE |
19 |
0.0027 |
| 599 |
RASH MACULO-PAPULAR |
60 |
0.0027 |
| 600 |
NEOPLASM |
31 |
0.0027 |
| 601 |
PROTEINURIA |
51 |
0.0027 |
| 602 |
APPENDICITIS |
25 |
0.0027 |
| 603 |
SPLENOMEGALY |
31 |
0.0026 |
| 604 |
SUDDEN DEATH |
28 |
0.0026 |
| 605 |
ABSCESS |
42 |
0.0026 |
| 606 |
PULMONARY MASS |
39 |
0.0026 |
| 607 |
HEPATITIS ACUTE |
17 |
0.0026 |
| 608 |
SUPRAVENTRICULAR TACHYCARDIA |
25 |
0.0026 |
| 609 |
CHOLESTASIS |
50 |
0.0026 |
| 610 |
SCOLIOSIS |
16 |
0.0026 |
| 611 |
NEPHROPATHY |
24 |
0.0026 |
| 612 |
HYPERGLYCAEMIA |
93 |
0.0025 |
| 613 |
CHOLECYSTITIS |
30 |
0.0025 |
| 614 |
GINGIVAL PAIN |
20 |
0.0025 |
| 615 |
METASTASES TO LUNG |
29 |
0.0025 |
| 616 |
TOXIC EPIDERMAL NECROLYSIS |
38 |
0.0025 |
| 617 |
PHARYNGITIS |
31 |
0.0025 |
| 618 |
DRUG ERUPTION |
44 |
0.0025 |
| 619 |
BRAIN OEDEMA |
31 |
0.0025 |
| 620 |
RENAL TUBULAR NECROSIS |
24 |
0.0024 |
| 621 |
HYPOMAGNESAEMIA |
34 |
0.0024 |
| 622 |
CEREBRAL DISORDER |
18 |
0.0024 |
| 623 |
ORAL CANDIDIASIS |
32 |
0.0024 |
| 624 |
UPPER RESPIRATORY TRACT INFECTION |
112 |
0.0024 |
| 625 |
PULMONARY EMBOLISM |
229 |
0.0024 |
| 626 |
SINUS TACHYCARDIA |
34 |
0.0024 |
| 627 |
HEPATITIS |
61 |
0.0024 |
| 628 |
GENERAL PHYSICAL CONDITION ABNORMAL |
16 |
0.0024 |
| 629 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
40 |
0.0023 |
| 630 |
HEPATITIS C |
28 |
0.0023 |
| 631 |
MOUTH HAEMORRHAGE |
17 |
0.0023 |
| 632 |
METASTASES TO BONE |
38 |
0.0023 |
| 633 |
LYMPHOEDEMA |
16 |
0.0023 |
| 634 |
THERAPY NON-RESPONDER |
104 |
0.0023 |
| 635 |
CEREBRAL HAEMORRHAGE |
82 |
0.0023 |
| 636 |
SMALL INTESTINAL OBSTRUCTION |
28 |
0.0023 |
| 637 |
HYPONATRAEMIA |
128 |
0.0023 |
| 638 |
BLOOD UREA INCREASED |
38 |
0.0023 |
| 639 |
HIATUS HERNIA |
29 |
0.0022 |
| 640 |
ARTERIOSCLEROSIS |
21 |
0.0022 |
| 641 |
VENTRICULAR EXTRASYSTOLES |
23 |
0.0022 |
| 642 |
TENDERNESS |
23 |
0.0022 |
| 643 |
CELLULITIS |
110 |
0.0022 |
| 644 |
SINUS BRADYCARDIA |
21 |
0.0022 |
| 645 |
ALTERED STATE OF CONSCIOUSNESS |
47 |
0.0022 |
| 646 |
HAEMATOCRIT DECREASED |
43 |
0.0022 |
| 647 |
NEURALGIA |
52 |
0.0021 |
| 648 |
END STAGE RENAL DISEASE |
39 |
0.0021 |
| 649 |
BLOOD CREATININE INCREASED |
139 |
0.0021 |
| 650 |
GASTRITIS |
56 |
0.0021 |
| 651 |
OEDEMA |
115 |
0.0021 |
| 652 |
JAUNDICE |
57 |
0.0021 |
| 653 |
DIALYSIS |
30 |
0.0021 |
| 654 |
GASTROINTESTINAL HAEMORRHAGE |
176 |
0.0021 |
| 655 |
DEAFNESS |
55 |
0.0021 |
| 656 |
HAEMATURIA |
72 |
0.0021 |
| 657 |
HYPERTHERMIA |
16 |
0.0021 |
| 658 |
HYPERLIPIDAEMIA |
25 |
0.0021 |
| 659 |
MOUTH ULCERATION |
44 |
0.0021 |
| 660 |
ASPARTATE AMINOTRANSFERASE INCREASED |
110 |
0.0021 |
| 661 |
LIVER DISORDER |
91 |
0.0020 |
| 662 |
HAEMORRHAGIC STROKE |
16 |
0.0020 |
| 663 |
PNEUMONIA ASPIRATION |
51 |
0.0020 |
| 664 |
PURPURA |
18 |
0.0020 |
| 665 |
DIARRHOEA HAEMORRHAGIC |
19 |
0.0020 |
| 666 |
PETECHIAE |
21 |
0.0020 |
| 667 |
GENERAL PHYSICAL HEALTH DETERIORATION |
231 |
0.0020 |
| 668 |
SUBARACHNOID HAEMORRHAGE |
20 |
0.0020 |
| 669 |
ACIDOSIS |
15 |
0.0020 |
| 670 |
FISTULA |
22 |
0.0020 |
| 671 |
HEPATIC FUNCTION ABNORMAL |
73 |
0.0020 |
| 672 |
HAEMORRHOIDS |
38 |
0.0019 |
| 673 |
ANOREXIA |
25 |
0.0019 |
| 674 |
INTERVERTEBRAL DISC PROTRUSION |
42 |
0.0019 |
| 675 |
TOOTH INFECTION |
25 |
0.0019 |
| 676 |
TACHYCARDIA |
168 |
0.0019 |
| 677 |
SUBDURAL HAEMATOMA |
27 |
0.0019 |
| 678 |
LEUKOCYTOSIS |
34 |
0.0019 |
| 679 |
DISORIENTATION |
74 |
0.0019 |
| 680 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
132 |
0.0019 |
| 681 |
ACUTE MYOCARDIAL INFARCTION |
54 |
0.0018 |
| 682 |
MELAENA |
40 |
0.0018 |
| 683 |
TOOTH FRACTURE |
20 |
0.0018 |
| 684 |
TRANSFUSION |
19 |
0.0018 |
| 685 |
SPINAL DISORDER |
17 |
0.0018 |
| 686 |
C-REACTIVE PROTEIN INCREASED |
65 |
0.0018 |
| 687 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
23 |
0.0018 |
| 688 |
BONE PAIN |
104 |
0.0018 |
| 689 |
MYOCARDIAL ISCHAEMIA |
20 |
0.0018 |
| 690 |
ORAL PAIN |
39 |
0.0017 |
| 691 |
HYPERKALAEMIA |
61 |
0.0017 |
| 692 |
PANCREATITIS ACUTE |
39 |
0.0017 |
| 693 |
ARRHYTHMIA |
82 |
0.0017 |
| 694 |
DELIRIUM |
60 |
0.0017 |
| 695 |
HYPOTENSION |
346 |
0.0017 |
| 696 |
HYPOPHAGIA |
44 |
0.0017 |
| 697 |
WHITE BLOOD CELL COUNT DECREASED |
186 |
0.0017 |
| 698 |
HEPATIC ENCEPHALOPATHY |
16 |
0.0017 |
| 699 |
OEDEMA PERIPHERAL |
208 |
0.0017 |
| 700 |
VENTRICULAR TACHYCARDIA |
28 |
0.0017 |
| 701 |
UNEVALUABLE EVENT |
127 |
0.0017 |
| 702 |
DIARRHOEA |
1080 |
0.0017 |
| 703 |
HAEMOGLOBIN DECREASED |
171 |
0.0017 |
| 704 |
MYOCARDITIS |
19 |
0.0017 |
| 705 |
PRODUCT USE ISSUE |
311 |
0.0017 |
| 706 |
OPTIC NEURITIS |
15 |
0.0016 |
| 707 |
BURSITIS |
20 |
0.0016 |
| 708 |
ALANINE AMINOTRANSFERASE INCREASED |
101 |
0.0016 |
| 709 |
DERMATITIS |
34 |
0.0016 |
| 710 |
SHOCK |
37 |
0.0016 |
| 711 |
GASTROINTESTINAL DISORDER |
144 |
0.0016 |
| 712 |
FACE OEDEMA |
27 |
0.0016 |
| 713 |
METASTASES TO LIVER |
28 |
0.0016 |
| 714 |
CARDIAC FAILURE CONGESTIVE |
127 |
0.0016 |
| 715 |
HAEMATEMESIS |
40 |
0.0016 |
| 716 |
SCAR |
27 |
0.0016 |
| 717 |
HYPERTENSION |
331 |
0.0016 |
| 718 |
HYPERCHOLESTEROLAEMIA |
15 |
0.0016 |
| 719 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
26 |
0.0015 |
| 720 |
TOOTH LOSS |
32 |
0.0015 |
| 721 |
RESPIRATORY DISORDER |
46 |
0.0015 |
| 722 |
SKIN LESION |
42 |
0.0015 |
| 723 |
CIRCULATORY COLLAPSE |
26 |
0.0015 |
| 724 |
RENAL DISORDER |
71 |
0.0015 |
| 725 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
60 |
0.0015 |
| 726 |
CARDIAC ARREST |
125 |
0.0015 |
| 727 |
MYOCLONUS |
18 |
0.0015 |
| 728 |
THYROID CANCER |
18 |
0.0015 |
| 729 |
LOWER RESPIRATORY TRACT INFECTION |
68 |
0.0015 |
| 730 |
DYSURIA |
55 |
0.0015 |
| 731 |
TOOTHACHE |
27 |
0.0015 |
| 732 |
STEVENS-JOHNSON SYNDROME |
33 |
0.0015 |
| 733 |
DIVERTICULITIS |
41 |
0.0015 |
| 734 |
TREATMENT FAILURE |
121 |
0.0015 |
| 735 |
VASCULITIS |
17 |
0.0015 |
| 736 |
GLAUCOMA |
28 |
0.0015 |
| 737 |
GENERALISED TONIC-CLONIC SEIZURE |
24 |
0.0014 |
| 738 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
32 |
0.0014 |
| 739 |
LIVER FUNCTION TEST INCREASED |
31 |
0.0014 |
| 740 |
TOOTH DISORDER |
32 |
0.0014 |
| 741 |
SKIN INFECTION |
16 |
0.0014 |
| 742 |
BLOOD CALCIUM DECREASED |
16 |
0.0014 |
| 743 |
MUSCULOSKELETAL CHEST PAIN |
22 |
0.0014 |
| 744 |
CARDIOVASCULAR DISORDER |
36 |
0.0014 |
| 745 |
OSTEOPOROSIS |
58 |
0.0014 |
| 746 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
35 |
0.0014 |
| 747 |
SKIN DISORDER |
47 |
0.0014 |
| 748 |
DYSPNOEA EXERTIONAL |
53 |
0.0014 |
| 749 |
ISCHAEMIC STROKE |
25 |
0.0014 |
| 750 |
CATARACT |
83 |
0.0014 |
| 751 |
OSTEOARTHRITIS |
59 |
0.0014 |
| 752 |
LIVER INJURY |
34 |
0.0014 |
| 753 |
ULCER |
22 |
0.0014 |
| 754 |
URINARY RETENTION |
46 |
0.0014 |
| 755 |
BRADYCARDIA |
73 |
0.0014 |
| 756 |
ASPIRATION |
15 |
0.0014 |
| 757 |
PERICARDITIS |
23 |
0.0014 |
| 758 |
ABNORMAL BEHAVIOUR |
54 |
0.0014 |
| 759 |
CEREBRAL INFARCTION |
33 |
0.0013 |
| 760 |
DEHYDRATION |
180 |
0.0013 |
| 761 |
CONVULSION |
77 |
0.0013 |
| 762 |
EPILEPSY |
41 |
0.0013 |
| 763 |
ANHEDONIA |
35 |
0.0013 |
| 764 |
RED BLOOD CELL COUNT DECREASED |
38 |
0.0013 |
| 765 |
INTESTINAL OBSTRUCTION |
50 |
0.0013 |
| 766 |
HYPOTHYROIDISM |
42 |
0.0013 |
| 767 |
PERITONITIS |
27 |
0.0013 |
| 768 |
THERAPEUTIC RESPONSE DECREASED |
79 |
0.0013 |
| 769 |
GASTRIC CANCER |
33 |
0.0013 |
| 770 |
LYMPHOCYTE COUNT DECREASED |
23 |
0.0013 |
| 771 |
EPISTAXIS |
97 |
0.0013 |
| 772 |
THROMBOSIS |
104 |
0.0013 |
| 773 |
POST PROCEDURAL HAEMORRHAGE |
15 |
0.0013 |
| 774 |
HEPATIC STEATOSIS |
24 |
0.0013 |
| 775 |
BRONCHITIS |
95 |
0.0013 |
| 776 |
ORAL HERPES |
25 |
0.0013 |
| 777 |
COLON CANCER |
19 |
0.0013 |
| 778 |
HAEMOPTYSIS |
35 |
0.0013 |
| 779 |
INFUSION RELATED REACTION |
83 |
0.0013 |
| 780 |
GINGIVAL BLEEDING |
17 |
0.0012 |
| 781 |
CONFUSIONAL STATE |
201 |
0.0012 |
| 782 |
CYSTITIS |
39 |
0.0012 |
| 783 |
SKIN REACTION |
17 |
0.0012 |
| 784 |
CONJUNCTIVITIS |
22 |
0.0012 |
| 785 |
MUSCLE ATROPHY |
15 |
0.0012 |
| 786 |
HEMIPARESIS |
20 |
0.0012 |
| 787 |
BODY TEMPERATURE INCREASED |
24 |
0.0012 |
| 788 |
INFLAMMATION |
60 |
0.0012 |
| 789 |
URINARY TRACT INFECTION |
198 |
0.0012 |
| 790 |
CHOLELITHIASIS |
38 |
0.0012 |
| 791 |
COVID-19 |
202 |
0.0012 |
| 792 |
DRUG INEFFECTIVE |
1496 |
0.0011 |
| 793 |
METABOLIC ACIDOSIS |
36 |
0.0011 |
| 794 |
PARALYSIS |
16 |
0.0011 |
| 795 |
MUSCULAR WEAKNESS |
125 |
0.0011 |
| 796 |
SYNCOPE |
110 |
0.0011 |
| 797 |
TRANSIENT ISCHAEMIC ATTACK |
37 |
0.0011 |
| 798 |
HAEMORRHAGE |
114 |
0.0011 |
| 799 |
CORONARY ARTERY DISEASE |
33 |
0.0011 |
| 800 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
28 |
0.0011 |
| 801 |
DRUG-INDUCED LIVER INJURY |
34 |
0.0011 |
| 802 |
PRESYNCOPE |
26 |
0.0011 |
| 803 |
FRACTURE |
20 |
0.0011 |
| 804 |
VISUAL ACUITY REDUCED |
35 |
0.0011 |
| 805 |
DYSPHAGIA |
100 |
0.0011 |
| 806 |
INJURY |
74 |
0.0011 |
| 807 |
CARDIO-RESPIRATORY ARREST |
44 |
0.0011 |
| 808 |
ANAPHYLACTIC SHOCK |
27 |
0.0010 |
| 809 |
FULL BLOOD COUNT DECREASED |
21 |
0.0010 |
| 810 |
POST PROCEDURAL COMPLICATION |
20 |
0.0010 |
| 811 |
DRUG INTOLERANCE |
100 |
0.0010 |
| 812 |
AGITATION |
76 |
0.0010 |
| 813 |
RECTAL HAEMORRHAGE |
44 |
0.0010 |
| 814 |
EAR INFECTION |
27 |
0.0010 |
| 815 |
VOMITING |
477 |
0.0010 |
| 816 |
DECREASED APPETITE |
232 |
0.0010 |
| 817 |
APHASIA |
30 |
0.0010 |
| 818 |
DRUG EFFECT INCOMPLETE |
36 |
0.0010 |
| 819 |
CONSTIPATION |
214 |
0.0010 |
| 820 |
AMENORRHOEA |
17 |
0.0010 |
| 821 |
HAEMATOMA |
25 |
0.0010 |
| 822 |
HALLUCINATION |
72 |
0.0010 |
| 823 |
MUSCULOSKELETAL PAIN |
50 |
0.0010 |
| 824 |
CARDIAC DISORDER |
89 |
0.0010 |
| 825 |
CHRONIC KIDNEY DISEASE |
72 |
0.0009 |
| 826 |
PRODUCTIVE COUGH |
45 |
0.0009 |
| 827 |
GASTROENTERITIS VIRAL |
17 |
0.0009 |
| 828 |
RASH ERYTHEMATOUS |
45 |
0.0009 |
| 829 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
49 |
0.0009 |
| 830 |
FEMUR FRACTURE |
29 |
0.0009 |
| 831 |
POLLAKIURIA |
39 |
0.0009 |
| 832 |
INFLUENZA |
104 |
0.0009 |
| 833 |
SKIN ULCER |
24 |
0.0009 |
| 834 |
LOCAL SWELLING |
16 |
0.0009 |
| 835 |
URINARY INCONTINENCE |
27 |
0.0009 |
| 836 |
ABDOMINAL PAIN |
212 |
0.0009 |
| 837 |
SINUS DISORDER |
18 |
0.0009 |
| 838 |
RASH |
395 |
0.0009 |
| 839 |
CHILLS |
106 |
0.0009 |
| 840 |
COMA |
43 |
0.0009 |
| 841 |
NIGHT SWEATS |
29 |
0.0009 |
| 842 |
WOUND |
25 |
0.0009 |
| 843 |
NEOPLASM MALIGNANT |
59 |
0.0009 |
| 844 |
BLINDNESS |
36 |
0.0009 |
| 845 |
HYPOAESTHESIA |
132 |
0.0009 |
| 846 |
PANCREATITIS |
46 |
0.0009 |
| 847 |
DIABETES MELLITUS |
66 |
0.0009 |
| 848 |
SINUSITIS |
88 |
0.0009 |
| 849 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
20 |
0.0009 |
| 850 |
UNRESPONSIVE TO STIMULI |
22 |
0.0009 |
| 851 |
LETHARGY |
49 |
0.0009 |
| 852 |
DIPLOPIA |
22 |
0.0008 |
| 853 |
DEATH |
729 |
0.0008 |
| 854 |
FLUID RETENTION |
43 |
0.0008 |
| 855 |
COUGH |
237 |
0.0008 |
| 856 |
FOOT FRACTURE |
16 |
0.0008 |
| 857 |
ANGINA PECTORIS |
24 |
0.0008 |
| 858 |
GOUT |
15 |
0.0008 |
| 859 |
PRODUCT PRESCRIBING ISSUE |
18 |
0.0008 |
| 860 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
24 |
0.0008 |
| 861 |
DISABILITY |
16 |
0.0008 |
| 862 |
ASTHENIA |
303 |
0.0008 |
| 863 |
OXYGEN SATURATION DECREASED |
45 |
0.0008 |
| 864 |
DISTURBANCE IN ATTENTION |
43 |
0.0008 |
| 865 |
DYSPNOEA |
450 |
0.0008 |
| 866 |
LACTIC ACIDOSIS |
25 |
0.0008 |
| 867 |
EAR PAIN |
15 |
0.0008 |
| 868 |
BLOOD POTASSIUM DECREASED |
23 |
0.0008 |
| 869 |
ERYTHEMA |
157 |
0.0008 |
| 870 |
NAUSEA |
603 |
0.0008 |
| 871 |
DEMENTIA |
21 |
0.0008 |
| 872 |
SWELLING |
70 |
0.0007 |
| 873 |
SKIN CANCER |
16 |
0.0007 |
| 874 |
RENAL INJURY |
22 |
0.0007 |
| 875 |
CONDITION AGGRAVATED |
216 |
0.0007 |
| 876 |
SEIZURE |
81 |
0.0007 |
| 877 |
ERECTILE DYSFUNCTION |
18 |
0.0007 |
| 878 |
PROSTATE CANCER |
56 |
0.0007 |
| 879 |
ADVERSE EVENT |
64 |
0.0007 |
| 880 |
LIVER FUNCTION TEST ABNORMAL |
20 |
0.0007 |
| 881 |
HIP FRACTURE |
22 |
0.0007 |
| 882 |
BACK PAIN |
158 |
0.0007 |
| 883 |
HAEMATOCHEZIA |
37 |
0.0007 |
| 884 |
PARAESTHESIA |
105 |
0.0007 |
| 885 |
ILL-DEFINED DISORDER |
40 |
0.0007 |
| 886 |
ABDOMINAL DISTENSION |
67 |
0.0006 |
| 887 |
WEIGHT DECREASED |
179 |
0.0006 |
| 888 |
ELECTROCARDIOGRAM QT PROLONGED |
23 |
0.0006 |
| 889 |
HEPATIC ENZYME INCREASED |
43 |
0.0006 |
| 890 |
MEDICATION ERROR |
35 |
0.0006 |
| 891 |
EMOTIONAL DISTRESS |
76 |
0.0006 |
| 892 |
INTENTIONAL PRODUCT MISUSE |
54 |
0.0006 |
| 893 |
RESPIRATORY ARREST |
17 |
0.0006 |
| 894 |
HYPOGLYCAEMIA |
29 |
0.0006 |
| 895 |
GASTROOESOPHAGEAL REFLUX DISEASE |
48 |
0.0006 |
| 896 |
FATIGUE |
462 |
0.0006 |
| 897 |
LUNG NEOPLASM MALIGNANT |
24 |
0.0006 |
| 898 |
HYPOACUSIS |
25 |
0.0006 |
| 899 |
ARTHROPATHY |
32 |
0.0006 |
| 900 |
TINNITUS |
26 |
0.0006 |
| 901 |
INTERNATIONAL NORMALISED RATIO INCREASED |
16 |
0.0006 |
| 902 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
16 |
0.0006 |
| 903 |
DRUG INTERACTION |
88 |
0.0006 |
| 904 |
WHITE BLOOD CELL COUNT INCREASED |
21 |
0.0005 |
| 905 |
ARTHRITIS |
43 |
0.0005 |
| 906 |
DISCOMFORT |
33 |
0.0005 |
| 907 |
WHEEZING |
32 |
0.0005 |
| 908 |
OROPHARYNGEAL PAIN |
49 |
0.0005 |
| 909 |
BLISTER |
28 |
0.0005 |
| 910 |
COGNITIVE DISORDER |
23 |
0.0005 |
| 911 |
ANAPHYLACTIC REACTION |
27 |
0.0005 |
| 912 |
CHEST PAIN |
89 |
0.0005 |
| 913 |
DYSARTHRIA |
18 |
0.0005 |
| 914 |
AMNESIA |
31 |
0.0005 |
| 915 |
FALL |
156 |
0.0005 |
| 916 |
TREMOR |
77 |
0.0005 |
| 917 |
NEPHROLITHIASIS |
21 |
0.0005 |
| 918 |
PAIN |
281 |
0.0005 |
| 919 |
GAIT DISTURBANCE |
87 |
0.0005 |
| 920 |
MYOCARDIAL INFARCTION |
78 |
0.0004 |
| 921 |
BREAST CANCER |
41 |
0.0004 |
| 922 |
ANXIETY |
123 |
0.0004 |
| 923 |
NECK PAIN |
24 |
0.0004 |
| 924 |
RASH MACULAR |
15 |
0.0004 |
| 925 |
WEIGHT INCREASED |
96 |
0.0004 |
| 926 |
TREATMENT NONCOMPLIANCE |
23 |
0.0004 |
| 927 |
CEREBROVASCULAR ACCIDENT |
71 |
0.0004 |
| 928 |
DYSPEPSIA |
41 |
0.0004 |
| 929 |
CONTUSION |
40 |
0.0004 |
| 930 |
MENTAL DISORDER |
18 |
0.0004 |
| 931 |
PAIN IN EXTREMITY |
121 |
0.0004 |
| 932 |
DRUG ABUSE |
34 |
0.0004 |
| 933 |
RHABDOMYOLYSIS |
17 |
0.0004 |
| 934 |
BLOOD PRESSURE DECREASED |
27 |
0.0004 |
| 935 |
SKIN EXFOLIATION |
34 |
0.0004 |
| 936 |
NASAL CONGESTION |
23 |
0.0004 |
| 937 |
DYSGEUSIA |
29 |
0.0004 |
| 938 |
SOMNOLENCE |
77 |
0.0004 |
| 939 |
DRY EYE |
19 |
0.0004 |
| 940 |
ADVERSE DRUG REACTION |
34 |
0.0004 |
| 941 |
MULTIPLE SCLEROSIS |
18 |
0.0004 |
| 942 |
DEPRESSION |
84 |
0.0004 |
| 943 |
DRY MOUTH |
29 |
0.0004 |
| 944 |
BLADDER CANCER |
21 |
0.0004 |
| 945 |
RHINORRHOEA |
23 |
0.0004 |
| 946 |
HYPERSENSITIVITY |
66 |
0.0004 |
| 947 |
HEART RATE INCREASED |
35 |
0.0004 |
| 948 |
SWELLING FACE |
23 |
0.0004 |
| 949 |
LOSS OF CONSCIOUSNESS |
45 |
0.0004 |
| 950 |
INSOMNIA |
93 |
0.0003 |
| 951 |
MOBILITY DECREASED |
25 |
0.0003 |
| 952 |
VISION BLURRED |
47 |
0.0003 |
| 953 |
OCULAR HYPERAEMIA |
16 |
0.0003 |
| 954 |
DIZZINESS |
166 |
0.0003 |
| 955 |
CHEST DISCOMFORT |
33 |
0.0003 |
| 956 |
VERTIGO |
19 |
0.0003 |
| 957 |
ABDOMINAL PAIN UPPER |
63 |
0.0003 |
| 958 |
MYALGIA |
51 |
0.0003 |
| 959 |
MUSCLE SPASMS |
55 |
0.0003 |
| 960 |
VISUAL IMPAIRMENT |
37 |
0.0003 |
| 961 |
RASH PRURITIC |
16 |
0.0003 |
| 962 |
SUICIDAL IDEATION |
27 |
0.0003 |
| 963 |
ARTHRALGIA |
118 |
0.0003 |
| 964 |
DYSPHONIA |
16 |
0.0003 |
| 965 |
SLEEP DISORDER |
19 |
0.0003 |
| 966 |
DRY SKIN |
35 |
0.0003 |
| 967 |
INJECTION SITE REACTION |
18 |
0.0003 |
| 968 |
ALOPECIA |
46 |
0.0002 |
| 969 |
PRURITUS |
90 |
0.0002 |
| 970 |
HEADACHE |
139 |
0.0002 |
| 971 |
INFLUENZA LIKE ILLNESS |
18 |
0.0002 |
| 972 |
FLUSHING |
22 |
0.0002 |
| 973 |
JOINT SWELLING |
26 |
0.0002 |
| 974 |
BURNING SENSATION |
15 |
0.0002 |
| 975 |
BLOOD PRESSURE INCREASED |
32 |
0.0002 |
| 976 |
MEMORY IMPAIRMENT |
26 |
0.0002 |
| 977 |
NO ADVERSE EVENT |
34 |
0.0002 |
| 978 |
ASTHMA |
20 |
0.0002 |
| 979 |
ABDOMINAL DISCOMFORT |
29 |
0.0002 |
| 980 |
HYPERHIDROSIS |
22 |
0.0002 |
| 981 |
HOSPITALISATION |
26 |
0.0002 |
| 982 |
MALAISE |
71 |
0.0002 |
| 983 |
BLOOD GLUCOSE INCREASED |
30 |
0.0002 |
| 984 |
URTICARIA |
26 |
0.0002 |
| 985 |
PALPITATIONS |
18 |
0.0002 |
| 986 |
PSORIASIS |
20 |
0.0002 |
| 987 |
PERIPHERAL SWELLING |
23 |
0.0001 |
| 988 |
NASOPHARYNGITIS |
24 |
0.0001 |
| 989 |
INJECTION SITE ERYTHEMA |
16 |
0.0001 |
| 990 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
18 |
0.0001 |
| 991 |
OVERDOSE |
18 |
0.0001 |